Pharma's Market
SPECIAL REPORT
- Tesla Unveils First SUV: Model X
- New York Fashion Week Hits the Runway as Colors Pop
- Mulling Buffett's Stock Advice? Get in With REITs: Fund Managers
- LinkedIn Earnings Bode Well for Hiring and Social Media
- Top Five Mistakes to Avoid in Online Dating
- Victor Cruz ‘Understands’ Gisele's Super Bowl Frustrations
- Tamminen: The United States of India
- Unusual Volume: Taleo Jumps After Oracle's $1.9 Billion Offer
- Warren Buffett: Stocks Will Outperform Gold and Bonds .. and They're Safer 'By Far'
- Stocks Looking Past Europe for a New Driver of the Rally
- Israel Likely to Bomb Iran This Year: Political Analyst
- Greeks Strike Against Austerity, EU Demands More Cuts
- EU Agrees Rules for $700 Trillion Derivatives Market
- The World's Best Beers
- Citigroup Takes $50 Million Loss in Lending Rate Probe
- Barclays Warns May Miss Medium-Term Profit Goal
- Will Romney Regret Opposing Michigan Auto Bailout?
- In Europe, Stagnation as a Way of Life
RSS FEED
ASCO--The Videos
Text Size 
Reporter
Here are some of the video clips I've done today on ASCO (American Society of Clinical Oncology) conference in Chicago. It's the world's biggest cancer conference and Wall Street's most keenly-watched medical meeting.
The clips are in order, with most recent at the top.
Highlights of the conference.
A promising brain cancer vaccine that has shown new positive test results, with John Sampson, Duke University Medical Center.
A breakthrough for patients suffering from brain cancer.
Discussing breakthroughs in drug cancer drugs and a company outlook, with Sol Barer, Celgene CEO.
ImClone's Erbitrux lung cancer drug is grabbing the spotlight.
Researchers will unveil new clinical trial results on a promising treatment for brain cancer.
An outlook on Genentech from ASCO, with Dr. Susan Desmond-Hellmann, former oncologist.
Deatils on the conference.
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes
